Semaglutide is gaining traction as a novel treatment for type 2 diabetes. This engineered glucagon-like peptide-1 (GLP-1) receptor agonist functions through stimulating the pancreas to release more insulin and reducing https://lewisfcaj221722.buyoutblog.com/35641408/understanding-semaglutide-a-comprehensive-guide